professional article 4

Long-lasting Zyprexa gets FDA nod

Lurasidone Effective in Adult Schizophrenia With Few Adverse Metabolic Effects

INVEGA(R) SUSTENNA(TM) Statistically Similar to RISPERDAL(R) CONSTA(R) Long-Acting Injection

Fanapt(TM) Launches in the United States, January 11 2010

Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Historical perspective on antipsychotic long-acting injections

NAMI's Survey on Depression: Summary of Findings Gaps & Guideposts

You Tube Video on What is Schizophrenia: by Dr. Ken Duckworth

Latest Industry News

PROFESSIONALS

CONSUMERS/FAMILIES

Medicare Part D:

Understanding the plan and your options Power Point Presentation
Barry Klein, Pharmacist

(PowerPoint may be required in order to view this presentation)

Visit the Mental Health Journal Message Board